IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jarvis, B. W.
Right arrow Articles by Splitter, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarvis, B. W.
Right arrow Articles by Splitter, G. A.

 Previous Article  |  Next Article 

Infection and Immunity, December 2002, p. 7165-7168, Vol. 70, No. 12
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.12.7165-7168.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Rough Lipopolysaccharide from Brucella abortus and Escherichia coli Differentially Activates the Same Mitogen-Activated Protein Kinase Signaling Pathways for Tumor Necrosis Factor Alpha in RAW 264.7 Macrophage-Like Cells

Bruce W. Jarvis, Tajie H. Harris, Nilofer Qureshi,{dagger} and Gary A. Splitter*

Animal Health and Biomedical Sciences Department, University of Wisconsin, Madison, Wisconsin 53706

Received 10 April 2002/ Returned for modification 29 June 2002/ Accepted 20 August 2002

The intracellular, gram-negative pathogen Brucella abortus establishes chronic infections in host macrophages while downregulating cytokines such as tumor necrosis factor alpha (TNF-{alpha}). When producing TNF-{alpha}, Brucella abortus rough lipopolysaccharide (LPS) activates the same mitogen-activated protein kinase signaling pathways (ERK and JNK) as Escherichia coli LPS, but Brucella LPS is a much less potent agonist.


* Corresponding author. Mailing address: Animal Health and Biomedical Sciences Department, 1656 Linden Dr., University of Wisconsin, Madison, WI 53706. Phone: (608) 262-1837. Fax: (608) 262-7420. E-mail: splitter{at}ahabs.wisc.edu.

Editor: V. J. DiRita

{dagger} Present address: Department of Basic Medical Sciences, Medical School, University of Missouri, Kansas City, MO 64108.


Infection and Immunity, December 2002, p. 7165-7168, Vol. 70, No. 12
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.12.7165-7168.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2002 by the American Society for Microbiology. All rights reserved.